CLINICAL_TRIALS
trial_result
· 2022-04-13
Clinical Trial Update: A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel [Phase 1]
Summary
Phase 1 study evaluating bioequivalence of Oraxol in cancer patients treated with intravenous paclitaxel has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Athenex, Inc. | Conditions: Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2022-04-13